| Dr Robert D Head And Dr Jennifer L Head Llc | |
|
1302 Sw C Ave, Lawton, OK 73501-4243 | |
| (580) 355-1298 | |
| (580) 581-7201 |
| Full Name | Dr Robert D Head And Dr Jennifer L Head Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1302 Sw C Ave, Lawton, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043426901 | NPI | - | NPPES |
| 100763770A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1049 (Oklahoma) | Primary |
| Provider Name | Kristina L Flint |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1952430480 PECOS PAC ID: 1658397427 Enrollment ID: I20051208000513 |
News Archive
Politico looks at the how the law squares with what it promised and talks to consumers in Kentucky about their expectations. Also, the Wall Street Journal examines one of the tactics health insurers are using to keep healthy customers.
SciDev.Net examines a recent conference in Cape Town, South Africa, where almost "300 researchers and health policymakers from across the continent" came together and approved a 2010-2015 business plan for the the African Network for Drugs and Diagnosis Innovation (ANDI).
Can the government really tell us what to buy? Federal judges have come down on both sides of the question, leaving it to the Supreme Court to sort out. The justices are allotting an unusually long period, six hours over three days, beginning March 26, to hear arguments challenging the law's constitutionality. Their ruling, expected in June, is shaping up as a historic moment in the century-long quest by reformers to provide affordable health care for all.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
› Verified 7 days ago
| Provider Name | Robert Head |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356470975 PECOS PAC ID: 6002029311 Enrollment ID: I20111207000867 |
News Archive
Politico looks at the how the law squares with what it promised and talks to consumers in Kentucky about their expectations. Also, the Wall Street Journal examines one of the tactics health insurers are using to keep healthy customers.
SciDev.Net examines a recent conference in Cape Town, South Africa, where almost "300 researchers and health policymakers from across the continent" came together and approved a 2010-2015 business plan for the the African Network for Drugs and Diagnosis Innovation (ANDI).
Can the government really tell us what to buy? Federal judges have come down on both sides of the question, leaving it to the Supreme Court to sort out. The justices are allotting an unusually long period, six hours over three days, beginning March 26, to hear arguments challenging the law's constitutionality. Their ruling, expected in June, is shaping up as a historic moment in the century-long quest by reformers to provide affordable health care for all.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
› Verified 7 days ago
| Provider Name | Kyle R Head |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1386970895 PECOS PAC ID: 3072779065 Enrollment ID: I20120718000895 |
News Archive
Politico looks at the how the law squares with what it promised and talks to consumers in Kentucky about their expectations. Also, the Wall Street Journal examines one of the tactics health insurers are using to keep healthy customers.
SciDev.Net examines a recent conference in Cape Town, South Africa, where almost "300 researchers and health policymakers from across the continent" came together and approved a 2010-2015 business plan for the the African Network for Drugs and Diagnosis Innovation (ANDI).
Can the government really tell us what to buy? Federal judges have come down on both sides of the question, leaving it to the Supreme Court to sort out. The justices are allotting an unusually long period, six hours over three days, beginning March 26, to hear arguments challenging the law's constitutionality. Their ruling, expected in June, is shaping up as a historic moment in the century-long quest by reformers to provide affordable health care for all.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert D Head And Dr Jennifer L Head Llc 1302 Sw C Ave, Lawton, OK 73501-4243 Ph: (580) 355-1298 | Dr Robert D Head And Dr Jennifer L Head Llc 1302 Sw C Ave, Lawton, OK 73501-4243 Ph: (580) 355-1298 |
News Archive
Politico looks at the how the law squares with what it promised and talks to consumers in Kentucky about their expectations. Also, the Wall Street Journal examines one of the tactics health insurers are using to keep healthy customers.
SciDev.Net examines a recent conference in Cape Town, South Africa, where almost "300 researchers and health policymakers from across the continent" came together and approved a 2010-2015 business plan for the the African Network for Drugs and Diagnosis Innovation (ANDI).
Can the government really tell us what to buy? Federal judges have come down on both sides of the question, leaving it to the Supreme Court to sort out. The justices are allotting an unusually long period, six hours over three days, beginning March 26, to hear arguments challenging the law's constitutionality. Their ruling, expected in June, is shaping up as a historic moment in the century-long quest by reformers to provide affordable health care for all.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
› Verified 7 days ago
Dr. Brandon Knox Ross, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4250 Nw Cache Rd., Lawton, OK 73505 Phone: 580-353-5090 Fax: 580-353-5105 | |
Dr. Ronald Edward Sellers, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1515 Lawrie Tatum Rd, Lawton, OK 73507 Phone: 580-353-0350 Fax: 580-355-6234 | |
Dr. Jeremy A Wiggins, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 901 Sw Goodyear Blvd, Lawton, OK 73505 Phone: 580-531-5790 Fax: 580-510-6307 | |
Dr. James Alan Edwards, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 409 Sw C Ave, Lawton, OK 73501 Phone: 580-248-5280 Fax: 580-357-0301 | |
Dr. Laura Elaine England, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4250 Nw Cache Rd., Lawton, OK 73505 Phone: 580-353-5090 | |
John E Barnes Jr Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Gore Blvd, Lawton, OK 73501 Phone: 580-355-3036 Fax: 580-248-1162 |